From Synthetic Biology to Emerging Technologies with Justin Eyquem, PhD

In this episode, Justin Eyquem, PhD, Parker Senior Fellow and PICI Member Researcher at the University of California, San Francisco, talks about his visionary work pioneering CAR-T cell therapies and synthetic biology with PICI Chief Scientific Officer John Connolly, PhD.

Listen as Justin provides an inside look at the CAR-T revolution, from next-generation therapies to cutting-edge advancements like in vivo delivery and AI-powered design. Hear him discuss his journey from bioengineering student to gene-editing innovator with support from PICI’s collaborative network of experts and resources.

Get ready to go from bench to fireside with Justin Eyquem, PhD.

++

From Bench to Fireside™ is a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients. Along the way, they unpack the hurdles encountered and the opportunities that lie ahead.

Tune in to hear from scientific leaders who stand at the forefront of developing breakthrough immune therapies with the goal of turning all cancers into curable diseases. From Bench to Fireside™ is produced by the Parker Institute for Cancer Immunotherapy. Follow PICI on LinkedIn, X @parkerici or visit www.parkerici.org.